Nicotinamide phosphoribosyltransferase (NAMPT) and nicotinate
phosphoribosyltransferase (NAPRT) are two intracellular enzymes that catalyze the first step …

Current pharmacotherapeutic options for treating obesity and related metabolic disorders
remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis …

Background—Adropin is a recently identified protein that has been implicated in the
maintenance of energy homeostasis and insulin resistance. Because vascular function and …

As a potential bioactive material, β-calcium silicate (β-CS) has attracted particular attention
in the field of bone regeneration. In this study, porous β-CS/Poly-d, l-Lactide-Glycolide …

Endothelial dysfunction is defined as impairment of the balance between endothelium‐
dependent vasodilation and constriction. Despite evidence of uric acid‐induced endothelial …

Abdominal obesity is a major risk factor for cardiovascular disease, and recent studies
highlight a key role of adipose tissue dysfunction, inflammation, and aberrant adipokine …

Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors
termed adipokines. Visfatin was initially identified as a novel adipokine with insulin‐mimetic …

Until the identification of leptin, the first adipokine discovered in 1994, adipose tissue was
considered only as an energy storage tissue. However, it is now clear that adipose tissue is …

In this review, we focus on the secreted form of nicotinamide phosphoribosyltransferase
(NAMPT); extracellular NAMPT (eNAMPT), also known as pre‐B cell colony‐enhancing …

Atherosclerosis (AS) is a chronic disease with a complex pathology that may lead to several
cardiovascular and cerebrovascular diseases; however, further research is necessary to …